Data released today by the Centers for Disease Control and Prevention (CDC) showed the total number of reports (including foreign and U.S.) of deaths following COVID vaccination, across all age groups, surpassed 12,000.
The data comes directly from reports submitted to the Vaccine Adverse Event Reporting System (VAERS), the primary government-funded system for reporting adverse vaccine reactions in the U.S.
Every Friday, VAERS makes public all vaccine injury reports received as of a specified date, usually about a week prior to the release date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.
Data released today show that between Dec. 14, 2020 and July 30, 2021, a total of 545,338 total adverse events were reported to VAERS, including 12,366 deaths — an increase of 426 over the previous week. There were 70,105 reports of serious injuries, including deaths, during the same time period — up 7,003 compared with the previous week.
Excluding “foreign reports” filed in VAERS, 443,201 adverse events, including 5,739 deaths and 35,881 serious injuries, were reported in the U.S.
In the U.S., 344.9 million COVID vaccine doses had been administered as of July 30. This includes: 139 million doses of Moderna’s vaccine, 193 million doses of Pfizer and 13 million doses of the Johnson & Johnson (J&J) COVID vaccine.
Of the 5,739 U.S. deaths reported as of July 30, 13% occurred within 24 hours of vaccination, 19% occurred within 48 hours of vaccination and 34% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
This week’s U.S. data for 12- to 17-year-olds show:
The most recent reported deaths include a 15-year-old boy (VAERS I.D. 1498080) who previously had COVID, was diagnosed with cardiomyopathy in May 2021 and died four days after receiving his second dose of Pfizer’s vaccine on June 18, when he collapsed on the soccer field and went into ventricular tachycardia; and a 13-year-old girl (VAERS I.D. 1505250) who died after suffering a heart condition after receiving her first dose of Pfizer.
- Other deaths include two 13-year-old boys (VAERS I.D. 1406840 and 1431289) who died two days after receiving a Pfizer vaccine, a 13-year-old boy who died after receiving Moderna (VAERS I.D. 1463061), three 15-year-olds (VAERS I.D. 1187918, 1382906 and 1242573), five 16-year-olds (VAERS I.D. 1420630, 1466009, 1225942, 1475434, and 1386841) and three 17-year-olds (VAERS I.D. 1199455, 1388042 and 1420762).
- 2,323 reports of anaphylaxis among 12- to 17-year-olds with 99% of cases
attributed to Pfizer’s vaccine. - 406 reports of myocarditis and pericarditis (heart inflammation) with 402 cases attributed to Pfizer’s vaccine.
- 77 reports of blood clotting disorders, with all cases attributed to Pfizer.
This week’s total U.S. VAERS data, from Dec. 14, 2020 to July 30, 2021, for all age groups combined, show:
- 21% of deaths were related to cardiac disorders.
- 54% of those who died were male, 43% were female and the remaining death reports did not include gender of the deceased.
- The average age of death was 73.2.
- As of July 30, 2,636 pregnant women reported adverse events related to COVID vaccines, including 912 reports of miscarriage or premature birth.
- Of the 2,533 cases of Bell’s Palsy reported, 50% were attributed to Pfizer vaccinations, 43% to Moderna and 6% to J&J.
- 483 reports of Guillain-Barré Syndrome, with 40% of cases attributed to Pfizer, 35% to Moderna and 24% to J&J.
- 121,452 reports of anaphylaxis with 44% of cases attributed to Pfizer’s vaccine, 48% to Moderna and 8% to J&J.
- 8,048 reports of blood clotting disorders. Of those, 3,428 reports were attributed to Pfizer, 2,910 reports to Moderna and 1,665 reports to J&J.
- 2,018 cases of myocarditis and pericarditis with 1,275 cases attributed to Pfizer, 667 cases to Moderna and 71 cases to J&J’s COVID vaccine.
FDA eyes full approval of Pfizer vaccine by early next month
The U.S. Food and Drug Administration (FDA) has accelerated its timeline to fully approve Pfizer’s COVID vaccine — planning to complete the process by the beginning of September, people familiar with the effort told The New York Times.
President Biden said last week he expected a fully approved vaccine in early fall. But the FDA’s unofficial deadline is Labor Day or sooner, according to The Times.
The agency said in a statement its leaders recognized approval might inspire more public confidence and had “taken an all-hands-on-deck approach” to the work.
The FDA’s move is expected to kick off more vaccination mandates for hospital workers, college students and federal troops.
Federal regulators have been under growing public pressure to fully approve Pfizer’s vaccine ever since the company filed its application on May 7.
Vaccinated may play key role in aiding evolution of more dangerous COVID variants
According to research published last week in Scientific Reports, vaccinated people may play a key role in helping SARS-CoV-2 variants evolve into those that evade existing COVID vaccines.
Researchers identified three specific risk factors that favor the emergence and establishment of a vaccine-resistant strain. They are: a high probability of initial emergence of the resistant strain; a high number of infected individuals; and a low rate of vaccination.
However, the analysis also showed the highest risk for establishing a vaccine-resistant strain occurs when a large fraction of the population has already been vaccinated but the transmission is not controlled.
“When most people are vaccinated, the vaccine-resistant strain has an advantage over the original strain,” Simon Rella of the Institute of Science and Technology Austria, told CNN. “This means the vaccine-resistant strain spreads through the population faster at a time when most people are vaccinated.”
The data is consistent with a study released last week by the Centers for Disease Control and Prevention which showed vaccinated people may transmit the Delta variant — now responsible for 80% of COVID cases in the U.S. — just as easily as the unvaccinated.
As The Defender reported Aug. 3, World Health Organization (WHO) officials said they are still trying to understand why the Delta variant is more transmissible than the original COVID virus strain.
As COVID—especially Delta variant—surges among fully vaccinated, Brian Hooker, Ph.D., said the more variant deviates from original sequence used for vaccine, the less effective vaccine will be on variant.
SUBSCRIBE #TheDefender: https://t.co/zL66Edfiw5https://t.co/ukuh6XlMSu
— Robert F. Kennedy Jr (@RobertKennedyJr) August 4, 2021
“There are certain mutations in the Delta variant that, for example, allow the virus to adhere to a cell more easily,” said Dr. Maria Van Kerkhove, WHO’S technical lead on COVID, at a press briefing July 30. “There are some laboratory studies that suggest that there’s increased replication in some of the modeled human airway systems.”
The CDC warned lawmakers July 29 of new research indicating the Delta strain is more contagious than chickenpox. The variant also appears to have a longer transmission window than the original COVID strain, and may make older people sicker, even if they’ve been fully vaccinated, CNBC reported.
Brian Hooker, Ph.D., P.E., Children’s Health Defense chief scientific officer and professor of biology at Simpson University, said while the Delta variant is likely more transmissible, it’s also likely less pathogenic.
“What we’re seeing is virus evolution 101,” Hooker said.
He explained:
“Viruses like to survive, so killing the host (i.e. the human who is infected) defeats the purpose because killing the host kills the virus, too.
“For this reason, new variants of viruses that circulate widely through the population tend to become more transmissive but less pathogenic. In other words, they will spread more easily from person to person, but they will cause less damage to the host.”
Hooker said the more the variant deviates from the original sequence used for the vaccine, the less effective the vaccine will be on that variant, which could explain why fully vaccinated people are getting infected with the Delta variant.
But this isn’t the case for natural immunity, Hooker explained:
“The vaccine focuses on the spike protein, whereas natural immunity focuses on the entire virus. Natural immunity — with a more diverse array of antibodies and T-cell receptors — will provide better protection overall as it has more targets in which to attack the virus, whereas vaccine-derived immunity only focuses on one portion of the virus, in this case, the spike protein. Once that portion of the virus has mutated sufficiently, the vaccine no longer is effective.”
This post was originally published by Childrenshealthdefense.org.
Author
The agency said in a statement its leaders recognized approval might inspire more public confidence and had “taken an all-hands-on-deck approach” to the work.
And for those who are AWAKE we can only assume one thing:
the APPROVAL is to jab asap to cull asap! And verifies that God has opened our eyes to the diabolical crafty plans of the evil spirits.
Praise God for he opens eyes and hearts to protect and save those who love Him.
Thank you James for faithfully posting and keeping us all informed!